The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Early detection of lung cancer using cfDNA fragmentation.
 
Dimitrios Mathios
Stock and Other Ownership Interests - Delfi Diagnostics (I)
Research Funding - Delfi Diagnostics; Roche
Patents, Royalties, Other Intellectual Property - Combination of Immunotherapy with local chemotherapy for the treatment of malignancies; DETECTION OF LUNG CANCER USING CELL-FREE DNA FRAGMENTATION; Use of the ZMIZ1 marker in directing treatment and predicting survival in cancer
 
Jakob Sidenius Johansen
Patents, Royalties, Other Intellectual Property - Johns Hopkins University School of Medicine; University of Copenhagen
 
Stephen Cristiano
Research Funding - Delfi Diagnostics
Patents, Royalties, Other Intellectual Property - Johns Hopkins University School of Medicine
 
Jamie Medina
No Relationships to Disclose
 
Jillian Phallen
Stock and Other Ownership Interests - Delfi Diagnostics
Patents, Royalties, Other Intellectual Property - Johns Hopkins University (Inst)
 
Klaus Richter Larsen
No Relationships to Disclose
 
Daniel Bruhm
No Relationships to Disclose
 
Noushin Niknafs
No Relationships to Disclose
 
Hans J. Nielsen
Research Funding - Abbott Laboratories (Inst)
 
Gerrit A. Meijer
Research Funding - Exact Sciences (Inst); Hartwig Medical Foundation (Inst); Personal Genome Diagnostics (Inst); Sentinel Diagnostics (Inst); Sysmex (Inst)
Patents, Royalties, Other Intellectual Property - Several patents pending (Inst)
 
Claus Lindbjerg Andersen
Research Funding - C2i genomics (Inst); Delfi diagnostics (Inst); Natera (Inst)
 
Stig Egil Bojesen
No Relationships to Disclose
 
Robert Scharpf
Employment - Delfi Diagnostics
Stock and Other Ownership Interests - Delfi Diagnostics
Research Funding - Delfi Diagnostics
Patents, Royalties, Other Intellectual Property - Delfi Diagnostics
 
Victor E. Velculescu
Leadership - Delfi Diagnostics; Personal Genome Diagnostics
Stock and Other Ownership Interests - Delfi Diagnostics; Personal Genome Diagnostics
Honoraria - Bristol-Myers Squibb; Genentech; Merck; Takeda
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Delfi Diagnostics; Genentech; Merck; Personal Genome Diagnostics; Takeda
Research Funding - Delfi Diagnostics
Patents, Royalties, Other Intellectual Property - Delfi Diagnostics; Personal Genome Diagnostics; Qiagen; Sysmex; Ventana Medical Systems